India well-positioned to evolve as an innovation-led pharma nation over next 5 Years: CDSCO Read more
India’s pharma exports nearing $30 billion, with CRDMOs and GCCs driving next phase of innovation: EY-Parthenon–OPPI report Read more
Anil Matai, Director General of OPPI, on the Future of Indian Pharma: From Product Provider to Health Partner Read more